- Previous Close
316.00 - Open
303.00 - Bid 299.00 x --
- Ask 303.00 x --
- Day's Range
288.00 - 317.00 - 52 Week Range
288.00 - 834.00 - Volume
33,900 - Avg. Volume
75,986 - Market Cap (intraday)
2.497B - Beta (5Y Monthly) 1.27
- PE Ratio (TTM)
-- - EPS (TTM)
-67.65 - Earnings Date Feb 14, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Welby Inc. provides digital health solutions that help patients to get medical care services. The company offers services in the areas of diabetes mellitus, lifestyle related disease, mental illness, autoimmune disease, neurological disease, rare disease, oncology, and pain. It also engages in the medical data survey business; and operates apps, web services, and data management. The company was incorporated in 2011 and is based in Tokyo, Japan.
www.welby.jp54
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 4438.T
View MorePerformance Overview: 4438.T
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4438.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4438.T
View MoreValuation Measures
Market Cap
2.50B
Enterprise Value
1.39B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.57
Price/Book (mrq)
1.93
Enterprise Value/Revenue
2.55
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-152.27%
Return on Assets (ttm)
-34.47%
Return on Equity (ttm)
-83.83%
Revenue (ttm)
528M
Net Income Avi to Common (ttm)
-804M
Diluted EPS (ttm)
-67.65
Balance Sheet and Cash Flow
Total Cash (mrq)
740M
Total Debt/Equity (mrq)
23.89%
Levered Free Cash Flow (ttm)
-502.38M